Graham Meller of Buttonwood Marketing shares some results from a recent trial of continuous metals monitoring technology
Swiss CDMO Siegfried has signed binding agreements with Curia Global for the acquisition of a drug substances site in Grafton, Wisconsin. The deal is expected to close by 1 July, subject to customary closing conditions.
Luxembourg-based OCSiAl has completed construction of a 3,000 tonnes/year facility for water-based single-wall carbon nanotube (SWCNT) dispersions in Serbia to support the manufacture of high-performance batteries. It is due to begin production in Q3.
American start-up DMC Biotechnologies, which develops and produces chemicals and ingredients using precision fermentation, has agreed to create the ‘Biotech Open Platform’ in partnership with French industrial giants Danone and Michelin, and the investment bank Crédit Agricole.
The European Commission has approved the first Important Project of Common European Interest (IPCEI). Under IPCEI Med4Cure, member states will provide up to €1 billion in public funding, which is expected to unlock €5.9 billion more in private funding.
Mitra Chem, a specialist in lithium-ion battery materials, has formed a joint project with inks and pigments giant Sun Chemical to develop the first iron phosphate mass production capability in North America. This will be co-located with Mitra Chem's lithium iron phosphate (LFP) production.
BASF has revealed that it is collaborating with three German universities on a project to make fumaric acid from the Basfia succiniciproducens bacterium by fermentation.
Current Issue
BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in Austria
Scott Sandler from ABSG Consulting reveals the depth of the changes happening with the latest Rule chan
Agilent Technologies, a major player in analytical and clinical laboratory services, has agreed to acquire
Following public consultation, CEFIC has presented a paper with six recommendations in support of the Europ
Most Popular
Swiss CDMO Siegfried has signed binding agreements with Curia Global for the acquisition of a drug substances site in Grafton, Wisconsin. The deal is expected to close by 1 July, subject to customary closing conditions. No financial details are being disclosed, other than that the acquisition is being financed from existing funds and will not change the company’s outlook for 2024 and mid-term financial targets.
Mitra Chem, a specialist in lithium-ion battery materials, has formed a joint project with inks and pigments giant Sun Chemical to develop the first iron phosphate mass production capability in North America. This will be co-located with Mitra Chem's lithium iron phosphate (LFP) production.
American start-up DMC Biotechnologies, which develops and produces chemicals and ingredients using precision fermentation, has agreed to create the ‘Biotech Open Platform’ in partnership with French industrial giants Danone and Michelin, and the investment bank Crédit Agricole. The first-phase investment is over €16 million.